Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion description "[Variants in triggering receptor expressed on myeloid cells 2 (TREM2) confer high risk for Alzheimer's disease (AD) and other neurodegenerative diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion evidence source_evidence_literature NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion SIO_000772 25732305 NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion wasDerivedFrom befree-2016 NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_assertion wasGeneratedBy ECO_0000203 NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1267549.RA5IXv84RnAU_8_6538G0qd6bwK5kjGgTg7W5nf0J6Lfw130_provenance.